{
    "code": "01045701",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01045701",
    "time": "2021-05-07 03:03:22",
    "許可證字號": "衛署藥製字第045701號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/01\/08",
    "發證日期": "92\/08\/07",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00104570103",
    "中文品名": "阿雷彼阿慶注射液",
    "英文品名": "ALEVIATIN INJECTION",
    "適應症": "大發作型癲癇之控制、預防及治療神經外科手術所引起之癲癇發作。",
    "劑型": "270注射劑",
    "包裝": "10安瓿 盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "PHENYTOIN SODIUM",
    "限制項目": "01國　產 09委託製造",
    "申請商名稱": "620101P998  東生華製藥股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "6105200026  瑞士藥廠股份有限公司新市廠",
            "製造廠廠址": "台南市新市區中山路182號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2812000610",
            "成分名稱": "PHENYTOIN SODIUM",
            "含量描述": "(250MG)",
            "含量": "230.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Aleviatin Inj_藥品外觀-104-12-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01045701&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "12.附件十二 擬稿1100324-045701阿雷彼阿慶注射液-110-04-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01045701&Seq=012&Type=9"
        },
        {
            "title": "L403-01_LEA_ALEVIATIN_INJ_20151028-上傳版-104-11-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01045701&Seq=011&Type=9"
        },
        {
            "title": "12.附件十二 標籤_阿雷彼阿慶注射液5ml-1091021-110-04-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01045701&Seq=005&Type=8"
        },
        {
            "title": "12.附件十二 外盒_1614-321-東生華彩盒-1091019第5校-30度C-110-04-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01045701&Seq=004&Type=8"
        },
        {
            "title": "M4030-01_CTN_ALEVIATIN_INJ_5ML_10S_AMP_20151028-上傳版-104-11-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01045701&Seq=003&Type=8"
        }
    ]
}